| nucleosome disassembly | GO:0006337 | 1 | 0.882 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.867 | |
| regionalization | GO:0003002 | 337 | 0.772 | |
| gland development | GO:0048732 | 330 | 0.770 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.693 | |
| chromatin modification | GO:0016568 | 187 | 0.671 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.666 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.660 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.608 | |
| chromatin organization | GO:0006325 | 206 | 0.593 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.582 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.563 | |
| respiratory system development | GO:0060541 | 190 | 0.555 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.552 | |
| t cell differentiation | GO:0030217 | 174 | 0.551 | |
| rhythmic process | GO:0048511 | 174 | 0.547 | |
| t cell activation | GO:0042110 | 289 | 0.537 | |
| regulation of alpha beta t cell differentiation | GO:0046637 | 35 | 0.523 | |
| regulation of cd4 positive alpha beta t cell activation | GO:2000514 | 24 | 0.493 | |
| respiratory tube development | GO:0030323 | 167 | 0.462 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.433 | |
| camera type eye development | GO:0043010 | 266 | 0.416 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.406 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.399 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.395 | |
| chromatin assembly or disassembly | GO:0006333 | 16 | 0.393 | |
| negative regulation of t helper 2 cell differentiation | GO:0045629 | 4 | 0.384 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.383 | |
| skeletal system development | GO:0001501 | 356 | 0.379 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.376 | |
| digestive system development | GO:0055123 | 200 | 0.364 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.364 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.352 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.352 | |
| histone modification | GO:0016570 | 159 | 0.349 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.337 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.314 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.305 | |
| muscle tissue development | GO:0060537 | 308 | 0.305 | |
| cd4 positive alpha beta t cell differentiation involved in immune response | GO:0002294 | 28 | 0.303 | |
| regulation of cell activation | GO:0050865 | 289 | 0.293 | |
| t helper cell differentiation | GO:0042093 | 28 | 0.288 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.283 | |
| circadian rhythm | GO:0007623 | 114 | 0.278 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.275 | |
| myotube differentiation | GO:0014902 | 105 | 0.274 | |
| blastocyst development | GO:0001824 | 80 | 0.261 | |
| neural tube development | GO:0021915 | 160 | 0.257 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.254 | |
| hindbrain development | GO:0030902 | 128 | 0.250 | |
| heart morphogenesis | GO:0003007 | 178 | 0.244 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.242 | |
| lung development | GO:0030324 | 164 | 0.239 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.238 | |
| regulation of cd4 positive alpha beta t cell differentiation | GO:0043370 | 21 | 0.234 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.234 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.231 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.229 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.226 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.225 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.224 | |
| dna repair | GO:0006281 | 107 | 0.217 | |
| pharyngeal system development | GO:0060037 | 17 | 0.216 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.202 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.202 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.197 | |
| cellular response to peptide | GO:1901653 | 92 | 0.197 | |
| double strand break repair | GO:0006302 | 48 | 0.194 | |
| epidermis development | GO:0008544 | 187 | 0.193 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.191 | |
| axonogenesis | GO:0007409 | 274 | 0.191 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.190 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.185 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.185 | |
| alpha beta t cell activation involved in immune response | GO:0002287 | 31 | 0.182 | |
| cell fate commitment | GO:0045165 | 210 | 0.182 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.182 | |
| stem cell maintenance | GO:0019827 | 130 | 0.181 | |
| digestive tract development | GO:0048565 | 190 | 0.181 | |
| atrial septum primum morphogenesis | GO:0003289 | 3 | 0.180 | |
| positive regulation of growth | GO:0045927 | 104 | 0.178 | |
| multicellular organism growth | GO:0035264 | 161 | 0.178 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.177 | |
| gonad development | GO:0008406 | 141 | 0.174 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.174 | |
| response to peptide hormone | GO:0043434 | 127 | 0.172 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.172 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.170 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.170 | |
| embryonic placenta development | GO:0001892 | 98 | 0.170 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.166 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.163 | |
| response to peptide | GO:1901652 | 136 | 0.162 | |
| cell adhesion | GO:0007155 | 329 | 0.161 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.160 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.158 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.157 | |
| dna metabolic process | GO:0006259 | 303 | 0.155 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.155 | |
| protein acylation | GO:0043543 | 64 | 0.154 | |
| t cell differentiation involved in immune response | GO:0002292 | 30 | 0.151 | |
| positive regulation of alpha beta t cell differentiation | GO:0046638 | 28 | 0.151 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.149 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.144 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.143 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.138 | |
| immune effector process | GO:0002252 | 321 | 0.138 | |
| histone acetylation | GO:0016573 | 41 | 0.136 | |
| lung epithelial cell differentiation | GO:0060487 | 29 | 0.136 | |
| alpha beta t cell differentiation involved in immune response | GO:0002293 | 30 | 0.135 | |
| definitive hemopoiesis | GO:0060216 | 20 | 0.134 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.133 | Rat |
| neuron projection guidance | GO:0097485 | 141 | 0.132 | |
| stem cell differentiation | GO:0048863 | 268 | 0.131 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.130 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.129 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.129 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.127 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.126 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.126 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.125 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.124 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.124 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.122 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.122 | |
| male gamete generation | GO:0048232 | 285 | 0.122 | Mouse |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.121 | |
| cell fate specification | GO:0001708 | 72 | 0.118 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.117 | |
| regulation of t helper cell differentiation | GO:0045622 | 14 | 0.117 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.116 | |
| stem cell development | GO:0048864 | 219 | 0.116 | |
| maintenance of location | GO:0051235 | 89 | 0.115 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.114 | |
| adaptive immune response | GO:0002250 | 155 | 0.113 | |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.112 | Rat |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.112 | |
| skin development | GO:0043588 | 220 | 0.111 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.109 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.106 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.106 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.105 | |
| placenta development | GO:0001890 | 140 | 0.105 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.104 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.103 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.102 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.101 | |
| lung cell differentiation | GO:0060479 | 30 | 0.100 | |
| muscle fiber development | GO:0048747 | 76 | 0.099 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.099 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.099 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.098 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.097 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.097 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.096 | |
| amine metabolic process | GO:0009308 | 45 | 0.096 | |
| chemotaxis | GO:0006935 | 247 | 0.096 | |
| lipid storage | GO:0019915 | 36 | 0.096 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.096 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.095 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.094 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.093 | |
| diencephalon development | GO:0021536 | 63 | 0.090 | |
| extracellular structure organization | GO:0043062 | 148 | 0.090 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.090 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.089 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.089 | |
| response to growth factor | GO:0070848 | 198 | 0.088 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.088 | |
| liver development | GO:0001889 | 66 | 0.088 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.088 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.086 | |
| positive regulation of lymphocyte differentiation | GO:0045621 | 61 | 0.086 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.086 | |
| heterochromatin organization | GO:0070828 | 4 | 0.086 | |
| endomembrane system organization | GO:0010256 | 147 | 0.084 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.084 | |
| thymus development | GO:0048538 | 41 | 0.083 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.083 | |
| atp catabolic process | GO:0006200 | 55 | 0.081 | |
| ventricular septum development | GO:0003281 | 42 | 0.080 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.080 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.079 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.078 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.077 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.075 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.075 | |
| epithelial cell development | GO:0002064 | 159 | 0.075 | |
| protein processing | GO:0016485 | 163 | 0.075 | |
| positive regulation of alpha beta t cell activation | GO:0046635 | 39 | 0.074 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.074 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.074 | |
| muscle cell development | GO:0055001 | 133 | 0.074 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.074 | |
| histone methylation | GO:0016571 | 71 | 0.074 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.073 | |
| telencephalon development | GO:0021537 | 186 | 0.073 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.073 | |
| megakaryocyte differentiation | GO:0030219 | 26 | 0.073 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.072 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.072 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.071 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.071 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.071 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.070 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.070 | |
| somitogenesis | GO:0001756 | 69 | 0.070 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.070 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.070 | |
| gene silencing | GO:0016458 | 38 | 0.069 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.069 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.069 | |
| septum primum development | GO:0003284 | 4 | 0.069 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.069 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.068 | |
| neural tube formation | GO:0001841 | 108 | 0.068 | |
| somite development | GO:0061053 | 81 | 0.068 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.068 | |
| lung alveolus development | GO:0048286 | 45 | 0.067 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.067 | |
| dendrite development | GO:0016358 | 115 | 0.067 | |
| histone h3 acetylation | GO:0043966 | 14 | 0.067 | |
| regulation of protein processing | GO:0070613 | 96 | 0.066 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.066 | |
| organelle fission | GO:0048285 | 170 | 0.065 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.065 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.065 | |
| striated muscle cell development | GO:0055002 | 125 | 0.064 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.064 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.064 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.064 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.064 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.062 | |
| embryonic camera type eye development | GO:0031076 | 36 | 0.062 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.062 | |
| male sex differentiation | GO:0046661 | 109 | 0.062 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.062 | |
| chromatin assembly | GO:0031497 | 13 | 0.062 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.062 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.061 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.061 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.060 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.060 | |
| cellular response to lipid | GO:0071396 | 145 | 0.060 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.059 | |
| positive regulation of t cell differentiation | GO:0045582 | 52 | 0.059 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.059 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.059 | |
| bone development | GO:0060348 | 120 | 0.058 | |
| activation of immune response | GO:0002253 | 138 | 0.058 | |
| cell aggregation | GO:0098743 | 18 | 0.057 | |
| angiogenesis | GO:0001525 | 201 | 0.057 | |
| response to insulin | GO:0032868 | 100 | 0.057 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.057 | |
| regulation of cell growth | GO:0001558 | 91 | 0.056 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.056 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.055 | |
| response to radiation | GO:0009314 | 165 | 0.055 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.055 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.055 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.055 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.054 | |
| b cell activation | GO:0042113 | 161 | 0.054 | |
| cartilage development | GO:0051216 | 140 | 0.054 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.054 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.053 | |
| intracellular protein transport | GO:0006886 | 204 | 0.053 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.053 | |
| peptidyl threonine modification | GO:0018210 | 31 | 0.053 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.053 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.053 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.053 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.053 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.053 | |
| dna recombination | GO:0006310 | 92 | 0.053 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.053 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.053 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.053 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.052 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.052 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.052 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.052 | |
| granulocyte differentiation | GO:0030851 | 17 | 0.052 | |
| dna methylation | GO:0006306 | 43 | 0.052 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.052 | |
| locomotory behavior | GO:0007626 | 195 | 0.052 | |
| positive regulation of t helper 1 cell differentiation | GO:0045627 | 4 | 0.051 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.051 | |
| chromatin disassembly | GO:0031498 | 1 | 0.051 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.051 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.051 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.050 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.050 | |
| methylation | GO:0032259 | 134 | 0.050 | |
| lens morphogenesis in camera type eye | GO:0002089 | 24 | 0.050 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.050 | |
| fat cell differentiation | GO:0045444 | 160 | 0.049 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.049 | |
| regulation of type 2 immune response | GO:0002828 | 18 | 0.049 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.049 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.048 | |
| histone lysine methylation | GO:0034968 | 50 | 0.048 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.048 | |
| protein ubiquitination | GO:0016567 | 171 | 0.047 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.047 | |
| atp metabolic process | GO:0046034 | 75 | 0.047 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.047 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.047 | |
| chromatin silencing | GO:0006342 | 15 | 0.046 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.046 | |
| cell growth | GO:0016049 | 130 | 0.046 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.046 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.045 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.045 | |
| organ growth | GO:0035265 | 117 | 0.045 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.044 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.044 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.044 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.044 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.044 | |
| mesoderm development | GO:0007498 | 100 | 0.044 | |
| rna processing | GO:0006396 | 105 | 0.044 | |
| primary neural tube formation | GO:0014020 | 95 | 0.044 | |
| developmental cell growth | GO:0048588 | 84 | 0.044 | |
| response to light stimulus | GO:0009416 | 135 | 0.044 | |
| t helper 2 cell differentiation | GO:0045064 | 12 | 0.044 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.043 | |
| axon guidance | GO:0007411 | 141 | 0.043 | |
| spleen development | GO:0048536 | 39 | 0.043 | |
| cardiac septum morphogenesis | GO:0060411 | 46 | 0.043 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.043 | |
| male gonad development | GO:0008584 | 88 | 0.042 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.042 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.041 | |
| male meiosis | GO:0007140 | 37 | 0.041 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.041 | |
| regulation of cell motility | GO:2000145 | 236 | 0.041 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.041 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.041 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.041 | |
| blastocyst formation | GO:0001825 | 33 | 0.041 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.041 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.041 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.040 | |
| epithelial tube formation | GO:0072175 | 130 | 0.040 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.040 | |
| protein catabolic process | GO:0030163 | 221 | 0.040 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.040 | |
| regulation of transcription by chromatin organization | GO:0034401 | 0 | 0.040 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.039 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.039 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.039 | |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.039 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.039 | |
| segmentation | GO:0035282 | 93 | 0.039 | |
| nuclear division | GO:0000280 | 158 | 0.039 | |
| carbohydrate transport | GO:0008643 | 62 | 0.039 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.039 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 46 | 0.039 | |
| lipid localization | GO:0010876 | 126 | 0.039 | |
| positive regulation of cd4 positive alpha beta t cell differentiation | GO:0043372 | 14 | 0.038 | |
| response to uv | GO:0009411 | 44 | 0.038 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.038 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.038 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.038 | |
| limb morphogenesis | GO:0035108 | 149 | 0.038 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.038 | |
| organism emergence from protective structure | GO:0071684 | 4 | 0.038 | |
| striated muscle atrophy | GO:0014891 | 2 | 0.038 | |
| regulation of binding | GO:0051098 | 111 | 0.038 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.037 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.037 | |
| type 2 immune response | GO:0042092 | 23 | 0.037 | |
| mapk cascade | GO:0000165 | 281 | 0.037 | |
| regulation of system process | GO:0044057 | 200 | 0.037 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.037 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.037 | |
| appendage development | GO:0048736 | 166 | 0.037 | |
| metaphase anaphase transition of mitotic cell cycle | GO:0007091 | 9 | 0.037 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.037 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.037 | |
| chromatin remodeling | GO:0006338 | 32 | 0.036 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.036 | |
| endocrine system development | GO:0035270 | 98 | 0.036 | |
| histone h3 k9 methylation | GO:0051567 | 17 | 0.036 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.036 | |
| germ cell development | GO:0007281 | 185 | 0.036 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.035 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.035 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.035 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.035 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.035 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.035 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.035 | |
| molting cycle | GO:0042303 | 90 | 0.035 | |
| spermatogenesis | GO:0007283 | 284 | 0.035 | Mouse |
| gliogenesis | GO:0042063 | 141 | 0.035 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.035 | |
| dna modification | GO:0006304 | 50 | 0.035 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.035 | |
| protein methylation | GO:0006479 | 81 | 0.034 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.034 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.034 | |
| regulation of cell fate commitment | GO:0010453 | 19 | 0.034 | |
| ventricular septum morphogenesis | GO:0060412 | 27 | 0.034 | |
| hair cycle | GO:0042633 | 90 | 0.034 | |
| compound eye development | GO:0048749 | 1 | 0.034 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.034 | Mouse |
| positive regulation of production of molecular mediator of immune response | GO:0002702 | 45 | 0.033 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.033 | |
| oxidation reduction process | GO:0055114 | 342 | 0.033 | |
| maintenance of protein location in nucleus | GO:0051457 | 2 | 0.033 | |
| muscle adaptation | GO:0043500 | 39 | 0.033 | |
| epithelium migration | GO:0090132 | 63 | 0.033 | |
| lung epithelium development | GO:0060428 | 37 | 0.033 | |
| connective tissue development | GO:0061448 | 179 | 0.033 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.033 | |
| immunoglobulin production | GO:0002377 | 73 | 0.033 | |
| positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902043 | 13 | 0.033 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.033 | |
| autophagy | GO:0006914 | 45 | 0.033 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.033 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.032 | |
| cell aging | GO:0007569 | 35 | 0.032 | |
| hexose metabolic process | GO:0019318 | 98 | 0.032 | |
| stem cell proliferation | GO:0072089 | 117 | 0.032 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.032 | Rat |
| negative regulation of t cell differentiation | GO:0045581 | 23 | 0.031 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.031 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.031 | |
| synaptic transmission | GO:0007268 | 329 | 0.031 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.031 | |
| mrna transcription from rna polymerase ii promoter | GO:0042789 | 4 | 0.031 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.031 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.031 | |
| protein localization to organelle | GO:0033365 | 185 | 0.031 | |
| viral gene expression | GO:0019080 | 3 | 0.031 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.031 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.031 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.031 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.031 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.031 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.031 | |
| regulation of cell size | GO:0008361 | 72 | 0.030 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.030 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.030 | |
| cytokine production | GO:0001816 | 319 | 0.030 | Rat |
| regulation of organ growth | GO:0046620 | 61 | 0.030 | |
| gastrulation | GO:0007369 | 116 | 0.030 | |
| mrna metabolic process | GO:0016071 | 84 | 0.030 | |
| tube formation | GO:0035148 | 140 | 0.030 | |
| protein stabilization | GO:0050821 | 25 | 0.030 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.030 | |
| dna dependent dna replication maintenance of fidelity | GO:0045005 | 3 | 0.029 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.029 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.029 | |
| ventral spinal cord interneuron differentiation | GO:0021514 | 16 | 0.029 | |
| spinal cord development | GO:0021510 | 81 | 0.029 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.029 | |
| glial cell differentiation | GO:0010001 | 131 | 0.029 | |
| positive regulation of cd4 positive alpha beta t cell activation | GO:2000516 | 16 | 0.029 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.028 | |
| organelle assembly | GO:0070925 | 177 | 0.028 | |
| microtubule based process | GO:0007017 | 236 | 0.028 | |
| nucleosome positioning | GO:0016584 | 4 | 0.028 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.028 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.028 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.028 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.028 | |
| regulation of hippo signaling | GO:0035330 | 1 | 0.028 | |
| negative regulation of growth | GO:0045926 | 99 | 0.028 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.027 | |
| mrna transcription | GO:0009299 | 4 | 0.027 | |
| b cell differentiation | GO:0030183 | 78 | 0.027 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.027 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.027 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.027 | |
| developmental maturation | GO:0021700 | 193 | 0.027 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.027 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.027 | |
| protein maturation | GO:0051604 | 176 | 0.027 | |
| embryonic eye morphogenesis | GO:0048048 | 29 | 0.027 | |
| cell maturation | GO:0048469 | 127 | 0.027 | |
| female sex differentiation | GO:0046660 | 84 | 0.027 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.027 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.027 | |
| autonomic nervous system development | GO:0048483 | 43 | 0.026 | |
| regulation of glucose transport | GO:0010827 | 32 | 0.026 | |
| neuron projection extension | GO:1990138 | 64 | 0.026 | |
| response to monosaccharide | GO:0034284 | 67 | 0.026 | |
